{
  "trial_id": "NCT03343925",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "voluntarily signed informed consent form",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "\u226518 years of age on day of signing informed consent form",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "chronic HCV infection",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "recent injecting drug use (previous 6 months)",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "eligible for DAA therapy as per the Pharmaceutical Benefits Scheme (PBS) criteria",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "HIV-1 infected participants enrolled in the study must meet the following criteria",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "have HIV infection documented by any licensed rapid HIV test or HIV enzyme or chemiluminescence immunoassay (E/CIA) test kit at any time prior to study entry and confirmed by a licensed Western blot or a second antibody test by a method other than the initial rapid HIV and/or E/CIA, or by HIV-1 p24 antigen, or plasma HIV-1 RNA viral load",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "be on HIV Antiretroviral Therapy (ART) for at least 4 weeks prior to study entry using an ART regimen that is allowable with the intended DAA regimen as determined by the current PI and the Liverpool drug interaction website OR be naive to treatment with any antiretroviral therapy (ART) with a baseline CD4 count of >200 and have no plans to initiate ART treatment while participating in this study and through to at least Follow-up Week 4",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "the participant must be excluded from participating in the trial if the subject is unable or unwilling to provide informed consent or abide by the requirements of the study",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "The patient has chronic HCV infection and meets some inclusion criteria, but exclusion due to inability to provide informed consent is a concern.",
  "_meta": {
    "topic_id": "64",
    "trial_id": "NCT03343925",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}